These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
650 related articles for article (PubMed ID: 20024675)
21. High sensitive multiresidue analysis of pharmaceuticals and antifungals in surface water using U-HPLC-Q-Exactive Orbitrap HRMS. Application to the Danube river basin on the Romanian territory. Chitescu CL; Kaklamanos G; Nicolau AI; Stolker AA Sci Total Environ; 2015 Nov; 532():501-11. PubMed ID: 26100729 [TBL] [Abstract][Full Text] [Related]
22. Partition of endocrine-disrupting chemicals between colloids and dissolved phase as determined by cross-flow ultrafiltration. Liu R; Wilding A; Hibberd A; Zhou JL Environ Sci Technol; 2005 Apr; 39(8):2753-61. PubMed ID: 15884373 [TBL] [Abstract][Full Text] [Related]
23. Sorption of selected endocrine disrupting chemicals to different aquatic colloids. Zhou JL; Liu R; Wilding A; Hibberd A Environ Sci Technol; 2007 Jan; 41(1):206-13. PubMed ID: 17265949 [TBL] [Abstract][Full Text] [Related]
24. Influence of the natural colloids on the multi-phase distributions of antibiotics in the surface water from the largest lake in North China. Cheng D; Liu X; Zhao S; Cui B; Bai J; Li Z Sci Total Environ; 2017 Feb; 578():649-659. PubMed ID: 27842965 [TBL] [Abstract][Full Text] [Related]
25. Distribution and ecological risk of pharmaceuticals in surface water of the Yeongsan river, Republic of Korea. Na TW; Kang TW; Lee KH; Hwang SH; Jung HJ; Kim K Ecotoxicol Environ Saf; 2019 Oct; 181():180-186. PubMed ID: 31185432 [TBL] [Abstract][Full Text] [Related]
26. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Andreozzi R; Raffaele M; Nicklas P Chemosphere; 2003 Mar; 50(10):1319-30. PubMed ID: 12586163 [TBL] [Abstract][Full Text] [Related]
27. A year-long study of the spatial occurrence and relative distribution of pharmaceutical residues in sewage effluent, receiving marine waters and marine bivalves. McEneff G; Barron L; Kelleher B; Paull B; Quinn B Sci Total Environ; 2014 Apr; 476-477():317-26. PubMed ID: 24472720 [TBL] [Abstract][Full Text] [Related]
28. Pharmaceuticals and iodinated contrast media in a hospital wastewater: A case study to analyse their presence and characterise their environmental risk and hazard. Mendoza A; Aceña J; Pérez S; López de Alda M; Barceló D; Gil A; Valcárcel Y Environ Res; 2015 Jul; 140():225-41. PubMed ID: 25880605 [TBL] [Abstract][Full Text] [Related]
29. Improved removal of estrogenic and pharmaceutical compounds in sewage effluent by full scale granular activated carbon: impact on receiving river water. Grover DP; Zhou JL; Frickers PE; Readman JW J Hazard Mater; 2011 Jan; 185(2-3):1005-11. PubMed ID: 21035257 [TBL] [Abstract][Full Text] [Related]
30. Occurrence and modeling of pharmaceuticals on a sewage-impacted Mediterranean river and their dynamics under different hydrological conditions. Osorio V; Marcé R; Pérez S; Ginebreda A; Cortina JL; Barceló D Sci Total Environ; 2012 Dec; 440():3-13. PubMed ID: 23022258 [TBL] [Abstract][Full Text] [Related]
31. Multi-residue analytical method for human pharmaceuticals and synthetic hormones in river water and sewage effluents by solid-phase extraction and liquid chromatography-tandem mass spectrometry. Al-Odaini NA; Zakaria MP; Yaziz MI; Surif S J Chromatogr A; 2010 Oct; 1217(44):6791-806. PubMed ID: 20851398 [TBL] [Abstract][Full Text] [Related]
32. Human pharmaceuticals in wastewaters from urbanized areas of Argentina. Elorriaga Y; Marino DJ; Carriquiriborde P; Ronco AE Bull Environ Contam Toxicol; 2013 Apr; 90(4):397-400. PubMed ID: 23229304 [TBL] [Abstract][Full Text] [Related]
33. Redox-sensitivity and mobility of selected pharmaceutical compounds in a low flow column experiment. Banzhaf S; Nödler K; Licha T; Krein A; Scheytt T Sci Total Environ; 2012 Nov; 438():113-21. PubMed ID: 22982450 [TBL] [Abstract][Full Text] [Related]
34. Study of pharmaceuticals in surface and wastewater from Cuernavaca, Morelos, Mexico: Occurrence and environmental risk assessment. Rivera-Jaimes JA; Postigo C; Melgoza-Alemán RM; Aceña J; Barceló D; López de Alda M Sci Total Environ; 2018 Feb; 613-614():1263-1274. PubMed ID: 28962074 [TBL] [Abstract][Full Text] [Related]
35. The occurrence of antihistamines in sewage waters and in recipient rivers. Kosonen J; Kronberg L Environ Sci Pollut Res Int; 2009 Jul; 16(5):555-64. PubMed ID: 19337767 [TBL] [Abstract][Full Text] [Related]
36. A rational approach to selecting and ranking some pharmaceuticals of concern for the aquatic environment and their relative importance compared with other chemicals. Donnachie RL; Johnson AC; Sumpter JP Environ Toxicol Chem; 2016 Apr; 35(4):1021-7. PubMed ID: 26184376 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products. Liebig M; Moltmann JF; Knacker T Environ Sci Pollut Res Int; 2006 Mar; 13(2):110-9. PubMed ID: 16612900 [TBL] [Abstract][Full Text] [Related]
38. Occurrences of pharmaceuticals in drinking water sources of major river watersheds, China. Sun J; Luo Q; Wang D; Wang Z Ecotoxicol Environ Saf; 2015 Jul; 117():132-40. PubMed ID: 25847753 [TBL] [Abstract][Full Text] [Related]
39. Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the ebro river basin (northeast Spain). Gros M; Petrović M; Barceló D Environ Toxicol Chem; 2007 Aug; 26(8):1553-62. PubMed ID: 17702326 [TBL] [Abstract][Full Text] [Related]
40. Occurrence of diclofenac and selected metabolites in sewage effluents. Stülten D; Zühlke S; Lamshöft M; Spiteller M Sci Total Environ; 2008 Nov; 405(1-3):310-6. PubMed ID: 18640705 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]